IRIS
GATTEI, VALTER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 829
NA - Nord America 812
AS - Asia 535
SA - Sud America 71
Continente sconosciuto - Info sul continente non disponibili 37
AF - Africa 19
OC - Oceania 2
Totale 2.305
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 771
RU - Federazione Russa 248
SG - Singapore 178
IT - Italia 173
IE - Irlanda 111
CN - Cina 88
DE - Germania 73
SE - Svezia 64
VN - Vietnam 62
HK - Hong Kong 61
BR - Brasile 59
BD - Bangladesh 54
FR - Francia 44
IN - India 40
GB - Regno Unito 29
UA - Ucraina 22
CA - Canada 21
PL - Polonia 18
MX - Messico 11
FI - Finlandia 10
KR - Corea 8
LT - Lituania 7
AT - Austria 6
BJ - Benin 6
ID - Indonesia 6
JP - Giappone 6
TR - Turchia 6
AR - Argentina 5
ZA - Sudafrica 5
CZ - Repubblica Ceca 4
ES - Italia 4
IQ - Iraq 4
NL - Olanda 4
UZ - Uzbekistan 4
EG - Egitto 3
GR - Grecia 3
HR - Croazia 3
JM - Giamaica 3
KE - Kenya 3
PK - Pakistan 3
CH - Svizzera 2
CO - Colombia 2
EC - Ecuador 2
KG - Kirghizistan 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
PH - Filippine 1
PS - Palestinian Territory 1
TN - Tunisia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
ZM - Zambia 1
Totale 2.268
Salva come PNG Salva come JPEG
Città #
Dublin 110
San Jose 104
Ashburn 67
Singapore 63
Hong Kong 60
Council Bluffs 59
Jacksonville 43
Beijing 38
Columbus 29
Los Angeles 29
Moscow 24
Lauterbourg 23
Ho Chi Minh City 22
Novara 20
New York 18
St Louis 18
Warsaw 17
Milan 16
Boardman 15
Piemonte 15
Santa Clara 15
Vercelli 15
Lawrence 14
Princeton 14
San Bernardino 14
São Paulo 14
Chandler 12
Dearborn 12
Munich 11
Atlanta 9
Buffalo 9
Hanoi 9
Tornaco 9
Turin 9
Bremen 8
Denver 8
Falkenstein 8
Helsinki 8
Mexico City 8
Montreal 8
Orem 8
Seoul 8
Frankfurt am Main 7
Podenzano 7
Redondo Beach 7
Chennai 6
Cotonou 6
London 6
Manchester 6
Belo Horizonte 5
Boston 5
Chicago 5
Hillsboro 5
Rome 5
Roseto degli Abruzzi 5
Tokyo 5
Wilmington 5
Ann Arbor 4
Brooklyn 4
Da Nang 4
Dallas 4
Hangzhou 4
Nuremberg 4
Seattle 4
Somaglia 4
Stockholm 4
Toronto 4
Ankara 3
Athens 3
Brno 3
City of London 3
Grafing 3
Gunzenhausen 3
Istanbul 3
Jackson 3
Jakarta 3
Johannesburg 3
Kingston 3
Palermo 3
Phoenix 3
Poplar 3
San Mateo 3
Sorocaba 3
Tashkent 3
Vilnius 3
Amsterdam 2
Cagliari 2
Cologno Monzese 2
Delhi 2
Greer 2
Hackney 2
Houston 2
Lewisham 2
Mosul 2
Norwalk 2
Padua 2
Panama City 2
Piscataway 2
Rimini 2
Rio de Janeiro 2
Totale 1.229
Salva come PNG Salva come JPEG
Nome #
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 181
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement 148
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 134
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 110
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia 108
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 106
Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 105
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression 105
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways 97
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 95
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial 94
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study 94
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 94
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials 90
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases 89
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab 86
Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma 82
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemia 77
Quality assessment for PCR-based minimal residual disease in Lymphoma: 10 Years of cross-laboratory standardization process within the fondazione italiana linfomi MRD network 77
CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience 67
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA 64
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands 56
Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real‐World” study 53
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation 45
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study 23
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d positive CLL mainly expressed in trisomy 12 16
CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL 9
Totale 2.305
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202257 0 0 3 4 5 0 3 0 4 2 14 22
2022/2023212 15 13 17 0 10 15 7 15 109 1 3 7
2023/2024106 8 13 9 6 13 1 16 0 0 0 10 30
2024/2025328 7 0 9 2 11 14 41 79 66 21 14 64
2025/20261.279 51 40 53 128 173 104 154 194 95 120 127 40
2026/2027153 56 97 0 0 0 0 0 0 0 0 0 0
Totale 2.305